Добавил:
Sekretar
kiopkiopkiop18@yandex.ru
t.me/Prokururor I Вовсе не секретарь, но почту проверяю
Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз:
Предмет:
Файл:Ординатура / Хирургия / @xirurgi_2025 / @xirurgi_2025 - 771 - файл
.pdf
42
N. G. Johnson and N. Kadoglou
As discussed in the pathophysiology and pathogenesis, serum biomarkers in
patients with IGM are proving to be useful in the prediction of severity and recurrence and should be considered in the diagnostic workup as indicated, in particular
IL-6 and CRP as biomarkers for disease severity and NLR as a predictor of recurrence. IL-33 has been proposed as a biomarker to distinguish between breast cancer
and IGM alongside radiological and histological diagnostic ndings.
6 Summary
The disease process of idiopathic granulomatous mastitis is believed to be a result
of initial ductal epithelial damage. The gold standard of treatment and the duration
of intervention are not yet standardized with steroids, antibiotics, methotrexate, and
surgery as being the most commonly used interventions. Corynebacterium, particularly Corynebacterium kroppenstedtii, is the bacterial agent mostly identied as a
causative agent in the majority of cases reported. It has been seen as resistant to
beta-lactam antibiotics but responsive to antibiotics such as doxycycline, rifampicin, and clarithromycin.
Serum CRP and IL-6 levels and NLR are proposed biomarkers for the measurement of disease severity and time to resolution in patients with IGM.TREM-1 and
IL33 are triggers that have been implicated in the pathway of the disease process
and present themselves as potential targets in the management of IGM.The majority of literature presented is retrospective as the disease is rare, making the elucidation of management modalities challenging. Indeed, further research is required and
recent publications prove promising in the guidance of management to date.
References
1. Kessler E, Wolloch Y.Granulomatous mastitis: a lesion clinically simulating carcinoma. Am J
Clin Pathol. 1972;58:642–6. https://doi.org/10.1093/ajcp/58.6.642.
2. Martinez-Ramos D, Simon-Monterde L, Suelves-Piqueres C, Queralt-Martin R, GranelVillach L, Laguna-Sastre JM, etal. Idiopathic granulomatous mastitis: a systematic review of
3060 patients. Breast J. 2019;25:1245–50. https://doi.org/10.1111/tbj.13446.
3. Altintoprak F, Kivilcim T, Ozkan OV.Aetiology of idiopathic granulomatous mastitis. World J
Clin Cases. 2014;2:852–8. https://doi.org/10.12998/wjcc.v2.i12.852.
4. Sheybani F, Naderi HR, Gharib M, Sarvghad M, Mirfeizi Z.Idiopathic granulomatous mastitis: long-discussed but yet-to-be-known. Autoimmunity. 2016;49:236–9. https://doi.org/1
0.3109/08916934.2016.1138221.
5. Taylor GB, Paviour SD, Musaad S, Jones WO, Holland DJ.A clinicopathological review of 34
cases of inammatory breast disease showing an association between corynebacteria infection
and granulomatous mastitis. Pathology. 2003;35:109–19.
6. Kutsuna S, Mezaki K, Nagamatsu M, Kunimatsu J, Yamamoto K, Fujiya Y, etal. Two cases
of granulomatous mastitis caused by Corynebacterium kroppenstedtii infection in nulliparous

Microbiology andBiological Markers
Данная книга находится в списке для перевода на русский язык сайта https://meduniver.com/
43
young women with hyperprolactinemia. Intern Med. 2015;54:1815–8. https://doi.org/10.2169/
internalmedicine.54.4254.
7. Bercot B, Kannengiesser C, Oudin C, Grandchamp B, Sanson-le Pors MJ, Mouly S, etal. First
description of NOD2 variant associated with defective neutrophil responses in a woman with
granulomatous mastitis related to corynebacteria. J Clin Microbiol. 2009;47:3034–7. https://
doi.org/10.1128/JCM.00561- 09.
8. Mathelin C, Riegel P, Chenard MP, Tomasetto C, Brettes JP. Granulomatous mastitis and
corynebacteria: clinical and pathologic correlations. Breast J. 2005;11:357. https://doi.
org/10.1111/j.1075- 122X.2005.21562.x.
9. Sanchez Eluchans N, Barberis C, Cittadini R, Ozuna Villca AM, Veiga MF, Vilches V, et al.
Corynebacterium kroppenstedtii breast infections: report of four cases. Rev Argent Microbiol.
2021;53:304–8. https://doi.org/10.1016/j.ram.2021.01.002.
10. Li XQ, Wu HL, Yuan JP, etal. Bacteria associated with granulomatous lobular mastitis and
the potential for personalized therapy. J Investig Surg. 2022;35:164–70. https://doi.org/10.108
0/08941939.2020.1833262.
11. Wang J, Xu H, Li Z, Li F, Yang Y, Yu X, etal. Pathogens in patients with granulomatous lobular
mastitis. Int J Infect Dis. 2019;81:123–7. https://doi.org/10.1016/j.ijid.2019.01.034.
12. Kivilcim T, Altintoprak F, Memis B, Ferhatoğlu MF, Kartal A, Dikicier E, etal. Role of bacteriological agents in idiopathic granulomatous mastitis: real or not? Eur J Breast Health.
2018;15:32–6. https://doi.org/10.5152/ejbh.2018.4249.
13. Tan QT, Tay SP, Gudi MA, Nadkarni NV, Lim SH, Chuwa EWL. Granulomatous mastitis
and factors associated with recurrence: an 11-year single-Centre study of 113 patients in
Singapore. World J Surg. 2019;43:1737–45. https://doi.org/10.1007/s00268- 019- 05014- x.
14. Dobinson HC, Anderson TP, Chambers ST, Doogue MP, Seaward L, Werno AM.Antimicrobial
treatment options for granulomatous mastitis caused by Corynebacterium species. J Clin
Microbiol. 2015;53:2895–9. https://doi.org/10.1128/JCM.00760- 15.
15. Paviour S, Musaad S, Roberts S, Taylor G, Taylor S, Shore K, etal. Corynebacterium species isolated from patients with mastitis. Clin Infect Dis. 2002;35:1434–40. https://doi.
org/10.1086/344463.
16. Koksal H, Vatansev H, Artac H, Kadoglou N.The clinical value of interleukins-8, −10, and
−17 in idiopathic granulomatous mastitis. Clin Rheumatol. 2020;39:1671–7. https://doi.
org/10.1007/s10067- 020- 04925- 8.
17. Saydam M, Yilmaz KB, Sahin M, Yanik H, Akinci M, Yilmaz I, etal. New ndings on autoimmune etiology of idiopathic granulomatous mastitis: serum IL-17, IL-22 and IL-23 levels
of patients. J Investig Surg. 2021;34:993–7. https://doi.org/10.1080/08941939.2020.1725190.
18. Yigitbasi MR, Guntas G, Atak T, Sonmez C, Yalman H, Uzun H.The role of interleukin-33
as an inammatory marker in differential diagnosis of idiopathic granulomatous mastitis
and breast cancer. J Investig Surg. 2017;30:272–6. https://doi.org/10.1080/08941939.201
6.1240270.
19. Huang YM, Lo C, Cheng CF, Lu CH, Hsieh SC, Li KJ.Serum C-reactive protein and interleukin- 6 levels as biomarkers for disease severity and clinical outcomes in patients with idiopathic
granulomatous mastitis. J Clin Med. 2021;10:2077. https://doi.org/10.3390/jcm10102077.
20. Kany S, Vollrath JT, Relja B.Cytokines in inammatory disease. Int J Mol Sci. 2019;20:6008.
https://doi.org/10.3390/ijms20236008.
21. Kim S, Eliot M, Koestler DC, Wu WC, Kelsey KT.Association of neutrophil-to-lymphocyte
ratio with mortality and cardiovascular disease in the Jackson heart study and modication by the Duffy antigen variant. JAMA Cardiol. 2018;3:455–62. https://doi.org/10.1001/
jamacardio.2018.1042.
22. Templeton AJ, McNamara MG, Šeruga B, Vera-Badillo FE, Aneja P, Ocaña A, etal. Prognostic
role of neutrophil-to-lymphocyte ratio in solid tumors: a systematic review and meta-analysis.
J Natl Cancer Inst. 2014;106:dju124. https://doi.org/10.1093/jnci/dju124.
23. Zheng J, Cai J, Li H, Zeng K, He L, Fu H, etal. Neutrophil to lymphocyte ratio and platelet to
lymphocyte ratio as prognostic predictors for hepatocellular carcinoma patients with various

44
treatments: a meta-analysis and systematic review. Cell Physiol Biochem. 2017;44:967–81.
https://doi.org/10.1159/000485396.
24. Pan L, Du J, Li T, Liao H. Platelet-to-lymphocyte ratio and neutrophil-to-lymphocyte ratio
associated with disease activity in patients with Takayasu's arteritis: a case-control study. BMJ
Open. 2017;7:e014451. https://doi.org/10.1136/bmjopen- 2016- 014451.
25. Cetinkaya OA, Celik SU, Terzioglu SG, Eroglu A.The predictive value of the neutrophilto- lymphocyte and platelet-to-lymphocyte ratio in patients with recurrent idiopathic granulomatous mastitis. Eur J Breast Health. 2020;16:61–5. https://doi.org/10.5152/ejbh.2019.5187.
26. Ates D, Doner HC, Kurban S, Koksal H.The effect of soluble TREM-1in idiopathic granulomatous mastitis. Immunol Investig. 2022;51:839–50. https://doi.org/10.1080/08820139.202
1.1879846.
27. Gao S, Yi Y, Xia G, Yu C, Ye C, Tu F, et al. The characteristics and pivotal roles of triggering receptor expressed on myeloid cells-1 in autoimmune diseases. Autoimmun Rev.
2019;18:25–35. https://doi.org/10.1016/j.autrev.2018.07.008.
28. De la Fuente M, MacDonald TT, Hermoso MA.The IL-33/ST2 axis: role in health and disease.
Cytokine Growth Factor Rev. 2015;26:615–23. https://doi.org/10.1016/j.cytogfr.2015.07.017.
29. Shang J, Zhao J, Wu X, Xu Y, Xie J, Zhao J.Interleukin-33 promotes inammatory cytokine
production in chronic airway inammation. Biochem Cell Biol. 2015;93:359–66. https://doi.
org/10.1139/bcb- 2014- 0163.
30. Altintoprak F, Karakece E, Kivilcim T, Dikicier E, Cakmak G, Celebi F, et al. Idiopathic
granulomatous mastitis: an autoimmune disease? ScienticWorldJournal. 2013;2013:148727.
https://doi.org/10.1155/2013/148727.
31. Koksal H.The clinical utility of autoantibodies in patients with idiopathic granulomatous mastitis. J Investig Surg. 2022;35:325–9. https://doi.org/10.1080/08941939.2020.1861666.
N. G. Johnson and N. Kadoglou

Imaging Studies inIdiopathic
Данная книга находится в списке для перевода на русский язык сайта https://meduniver.com/
Granulomatous Mastitis
NevinSekmenli
1 Mammography
Idiopathic granulomatous mastitis (IGM), a chronic, benign, and inammatory disease of the breast, is frequently confused with malignant lesions due to its clinical
and radiological ndings. The rst radiological step in the breast imaging algorithm
is mammography. The sensitivity of mammography is lower among the young population due to the dense breast pattern [1–3].
Mammographic ndings are reported as negative in 50% of cases in the literature. However, in some cases, mammographic ndings are suspicious enough to
easily suggest malignancy [3]. The mammographic images may vary from one case
to another. Regarding mammography, an asymmetric density with no parenchymal
distortion or microcalcications and/or a mass with benign or suspicious properties
and focal asymmetric density may be seen. The most common mammographic
appearance in IGM is asymmetric density. In previous studies, dense or heterogeneous dense breast patterns were observed in more than half of the cases [4]. In a
study by Fazzio et al. [5], a moderate-sized focal asymmetry demonstrating the
region of palpable mass was observed as the most widespread nding on the mammography [5].
Focal asymmetry (Fig.1), asymmetric broglandular increase in density (Fig.2),
structural distortion (Fig.3), nipple retraction (Fig.4), retroareolar asymmetric den-
sity (Fig. 5), trabecular thickening (Fig. 6), irregular or ellipsoid-shape density
(Fig. 7), and multifocal involvement can be detected in the non-dense breasts.
Additionally, there may be a thickening of the skin in the supercially involved areas.
N. Sekmenli (*)
Department of Radiology, Saglik Bilimleri University, Hamidiye Faculty of Medicine,
Ministry of Health Konya City Hospital, Konya, Türkiye
H. Koksal, N. Kadoglou (eds.), Idiopathic Granulomatous Mastitis,
https://doi.org/10.1007/978-3-031-30391-3_7
45© The Author(s), under exclusive license to Springer Nature Switzerland AG 2023

46
Fig. 1 Mediolateral
oblique mammograms of
the right and left breasts of
a 41-year-old woman with
IGM.A focal asymmetric
density is seen in the upper
portion of the right breast
(arrow)
Fig. 2 A 36-year-old
woman with
IGM.Bilateral
mediolateral oblique
mammogram demonstrates
regional asymmetry with
indistinct margins in the
middle upper portion of the
left breast. The left breast
size has increased globally
N. Sekmenli

Imaging Studies inIdiopathic Granulomatous Mastitis
Данная книга находится в списке для перевода на русский язык сайта https://meduniver.com/
47
Fig. 3 Bilateral mediolateral oblique and craniocaudal mammograms of a 38-year-old woman
with IGM.A focal asymmetric density with indistinct margins is seen in the upper outer quadrant
of the right breast (arrows)
Fig. 4 Bilateral
mediolateral oblique
mammography of a patient
with pathologically proven
diagnosis of IGM.Skin
thickening and nipple
retraction of the left breast
is seen (arrow). Regional
asymmetry in the
retroareolar and lower
region of the left breast is
noticed. A wellcircumscribed solitary
mass in the upper right
breast has simple cystic
features sonographically

48
Fig. 5 Bilateral
mediolateral oblique
mammogram of a
28-year-old woman with
IGM on the left breast.
There is a regional
asymmetry and slightly
parenchymal distortion in
the retroareolar region of
the left breast (arrows)
Fig. 6 IGM on the left
breast in a woman. She has
a palpable mass in the
upper outer quadrant of the
left breast. Bilateral
mediolateral oblique
mammogram demonstrates
a large mass-like density
with trabecular thickening
in the upper quadrant of
the left breast (arrows)
N. Sekmenli
The cases of inammatory breast cancer (IBC) present with similar manifestations. However, IBC characteristically involves over one-third of the breast skin,
whereas IGM seldom involves the skin extensively [6].
In many patients, the affected breast is slightly larger than the opposite breast,
especially in a mediolateral oblique (MLO) view (Fig.2) [5].
IGM lesions can be observed in each quadrant of the breasts without any association with a specic quadrant.
In general, there is no relationship between IGM and calcications [5, 7]. Fazzio
etal. [5] reported that calcications are a very rare mammographic nding of granulomatous mastitis via a single case appearing as segmental coarse heterogeneous
calcications [5].

Imaging Studies inIdiopathic Granulomatous Mastitis
Данная книга находится в списке для перевода на русский язык сайта https://meduniver.com/
Fig. 7 Bilateral
mediolateral oblique
mammogram of a
28-year-old woman with
IGM on the left breast. A
nodular density with
indistinct margins is seen
in the retroareolar region
of the left breast (arrow).
Fibroglandular texture
distribution is symmetrical
in both breasts
2 Ultrasonography
49
Since IGM is encountered more commonly among premenopausal women presenting with mastitis and mass-like ndings, the rst-line diagnostic tool is examination
through breast ultrasonography (US), rather than mammography and breast magnetic resonance imaging (MRI). Ultrasonography is a very valuable modality in
IGM in the posttreatment follow-up phase, as well as its contribution to determining
the diagnosis. While the sensitivity of US in detecting lesions is high, its specicity
is low in the differential diagnosis of the lesions.
In addition to the algorithm for identied ndings, the radiologist’s comments
and recommendations should also be recorded in the breast imaging report.
Therefore, the use of the Breast Imaging Reporting and Data System (BI-RADS)
classication has been created and, thus, has enabled such interpretations to be
noted in standardized form [8]. The score of BI-RADS US includes the denition of
the lesion seen, the degree of suspicion, which lesions should be biopsied, and recommendations to the clinician. BI-RADS 2 refers to benign lesions with no risk of
malignancy.
In a previous study, 90% and 10% of IGM patients were reported to be dened
as BI-RADS 3 and BI-RADS 4 categories sonographically, respectively [3]. IGM
often mimics breast cancer clinically and radiologically, and the cases are commonly diagnosed as breast cancer initially [9]. Since the risk of breast cancer does
not increase because of IGM diagnosis throughout the lifetime, the correct diagnosis is important to avoid unnecessary mastectomy. Therefore, US investigation is
greatly benecial in the differential diagnosis.

50
N. Sekmenli
The most common sonographic nding in IGM is usually in the form of interconnected hypoechoic masses with irregular, ill-dened, and angled contours,
including sinus tracts extending into the neighboring parenchyma in heterogeneous
echoes in the peripheral sections of the breast (Figs.8 and 9) [2, 5]. The lesions are
almost always seen as parallel-orientated in the parenchyma.
Other common sonographic ndings include features such as thickening of the
breast skin (Fig.10), enlargement of the ductal structures (Fig.11), mass-like paren-
chymal distortion (Fig.12), uniform or heterogeneous masses with regular contours
(Fig.13), global edema in the breast tissue (Fig. 14), parenchymal heterogeneity
(Fig.15), accumulated dense abscess-like contents (Fig.16), tract formations opening to the skin or extending to the subcutaneous parenchyma (Fig. 15), and
hypoechogenic areas casting a focal acoustic shadow (Fig.17). Irregular contours,
microlobulated angulations, and heterogeneous parenchymal areas often raise the
suspicion of malignancy (Fig.18).
Fig. 8 Idiopathic
granulomatous mastitis: a
30-year-old woman.
Tubular connection (arrows
up) extending between the
breast lobules and
subcutaneous tissue.
Subcutaneous collection is
seen (arrow to right)
Fig. 9 A 36-year-old
woman with
IGM.Hypoechoic nodular
structures (stars) and
tubular connection
(arrows)

Imaging Studies inIdiopathic Granulomatous Mastitis
Данная книга находится в списке для перевода на русский язык сайта https://meduniver.com/
Fig. 10 A 36-year-old
woman with
IGM.Multiple irregular
hypoechoic masses and
collections with tubular
connection with ngerlike
aspects and thickening of
the skin (arrows)
Fig. 11 A 32-year-old
woman with
IGM.Hypoechoic nodular
structure (star) with ductal
ectasia (arrows)
51
Fig. 12 Idiopathic
granulomatous mastitis: a
30-year-old woman.
Ill-dened hypoechoic
concentrated collection
(arrows) is connected with
nodular hypoechoic
structure (star)
Соседние файлы в папке @xirurgi_2025
